SG11202008794TA - Non-hormonal compositions and methods for male contraception - Google Patents

Non-hormonal compositions and methods for male contraception

Info

Publication number
SG11202008794TA
SG11202008794TA SG11202008794TA SG11202008794TA SG11202008794TA SG 11202008794T A SG11202008794T A SG 11202008794TA SG 11202008794T A SG11202008794T A SG 11202008794TA SG 11202008794T A SG11202008794T A SG 11202008794TA SG 11202008794T A SG11202008794T A SG 11202008794TA
Authority
SG
Singapore
Prior art keywords
methods
male contraception
hormonal compositions
hormonal
compositions
Prior art date
Application number
SG11202008794TA
Other languages
English (en)
Inventor
Glaoui Guillaume El
Glaoui Mehdi El
Philippe Perrin
Stéphane Droupy
Véronique Agathon-Meriau
Original Assignee
Laboratoires Major
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Major filed Critical Laboratoires Major
Publication of SG11202008794TA publication Critical patent/SG11202008794TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
SG11202008794TA 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception SG11202008794TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
EP18305328 2018-03-23
PCT/EP2019/057267 WO2019180217A1 (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception

Publications (1)

Publication Number Publication Date
SG11202008794TA true SG11202008794TA (en) 2020-10-29

Family

ID=65955198

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202008794TA SG11202008794TA (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception

Country Status (19)

Country Link
US (3) US10912762B2 (https=)
EP (2) EP3562485B8 (https=)
JP (1) JP7270901B2 (https=)
KR (1) KR102496504B1 (https=)
CN (1) CN112074269A (https=)
AU (1) AU2019237228B2 (https=)
BR (1) BR112020018925A2 (https=)
CA (1) CA3094016C (https=)
DK (2) DK3750538T3 (https=)
ES (2) ES2989170T3 (https=)
FI (1) FI3750538T3 (https=)
IL (1) IL277372B2 (https=)
MA (1) MA53626B1 (https=)
MX (1) MX2020009937A (https=)
PL (2) PL3750538T3 (https=)
PT (1) PT3562485T (https=)
SG (1) SG11202008794TA (https=)
UA (1) UA128502C2 (https=)
WO (1) WO2019180217A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3750538T3 (pl) * 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę
AU2023384256A1 (en) * 2022-11-23 2025-03-20 Pharmajor Incorporated Modified-release silodosin compositions and use thereof in methods for male contraception

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
HUP0300128A3 (en) 2000-02-15 2004-03-29 Schering Ag Male contraceptive composition comprising norethisterone and its use
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20090186896A1 (en) * 2005-09-29 2009-07-23 Bayer Healthcare Ag PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
CN101316934A (zh) * 2005-09-29 2008-12-03 拜耳医药保健股份公司 用于治疗泌尿系统疾病的pde抑制剂及其组合
MX2009003737A (es) * 2006-10-05 2009-06-16 Panacea Biotec Ltd Composicion inyectable en deposito y su procedimiento de preparacion.
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
US20080242717A1 (en) 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
JPWO2016051782A1 (ja) 2014-09-30 2017-07-13 キッセイ薬品工業株式会社 苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
PL3750538T3 (pl) * 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę

Also Published As

Publication number Publication date
DK3750538T3 (da) 2024-09-23
EP3562485B1 (en) 2020-07-01
JP7270901B2 (ja) 2023-05-11
US11951095B2 (en) 2024-04-09
BR112020018925A2 (pt) 2020-12-29
IL277372B1 (en) 2023-05-01
MA53626B1 (fr) 2024-09-30
EP3750538B1 (en) 2024-08-14
JP2021518438A (ja) 2021-08-02
ES2813084T3 (es) 2021-03-22
IL277372A (en) 2020-11-30
PL3750538T3 (pl) 2024-11-25
US11583518B2 (en) 2023-02-21
PL3562485T3 (pl) 2020-11-16
AU2019237228A1 (en) 2020-10-01
EP3750538A1 (en) 2020-12-16
UA128502C2 (uk) 2024-07-31
US20210113526A1 (en) 2021-04-22
WO2019180217A1 (en) 2019-09-26
KR102496504B1 (ko) 2023-02-06
CA3094016A1 (en) 2019-09-26
US20230145374A1 (en) 2023-05-11
ES2989170T3 (es) 2024-11-25
PT3562485T (pt) 2020-08-27
IL277372B2 (en) 2023-09-01
CN112074269A (zh) 2020-12-11
EP3562485A1 (en) 2019-11-06
RU2020134408A (ru) 2022-04-29
FI3750538T3 (fi) 2024-09-24
MA53626A (fr) 2022-03-09
US10912762B2 (en) 2021-02-09
AU2019237228B2 (en) 2023-06-08
US20190290615A1 (en) 2019-09-26
NZ767741A (en) 2024-11-29
MX2020009937A (es) 2022-09-30
RU2020134408A3 (https=) 2022-04-29
KR20200135978A (ko) 2020-12-04
DK3562485T3 (da) 2020-08-24
CA3094016C (en) 2023-10-10
EP3562485B8 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
IL277079A (en) Cartirin preparations and methods of use
IL280508A (en) The composition and methods of producing geopolymer
IL280134A (en) Anti-CD112R preparations and methods
SG11202011761XA (en) Nicotine formulation
HUE052749T2 (hu) Meloxicamot és rizatriptant tartalmazó gyógyászati készítmények
SMT202200251T1 (it) Composizioni e metodi per ridurre la neovascolarizzazione oculare
EP3242631A4 (en) Prosthesis for improved penis function
SG11202104448WA (en) Compositions and methods
IL274524A (en) Preparations and methods for aquaculture
GB201817444D0 (en) Methods and compositions
IL277372A (en) Non-hormonal preparations and methods for preventing pregnancy in men
ZA202008034B (en) Ivosidenib forms and pharmaceutical compositions
SG11202103389WA (en) Immunogenic compositions
EP3556329C0 (en) LUBRICANT CONDOM
GB201819987D0 (en) Methods and compositions
GB201804092D0 (en) Methods and compositions
IL282515A (en) Preparations and methods for improving sperm function
HK40012009A (en) Non-hormonal compositions and methods for male contraception comprising (r)-silodosin
HK40012009B (en) Non-hormonal compositions and methods for male contraception comprising (r)-silodosin
PT3750538T (pt) Métodos não-hormonais para a contracepção masculina compreendendo (r)-silodosina
SMT202400035T1 (it) Formulazione intravaginale
IL264898A (en) Formulations of cysteamine and its derivatives
GB201817902D0 (en) Methods and compositions
GB201812022D0 (en) Pharmaceutical methods and compositions
GB201809880D0 (en) Compositions and methods